0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Targeted Radiotherapy Drug Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-2U15903
Home | Market Reports | Health| Health Conditions| Cancer
Global Targeted Radiotherapy Drug Market Research Report 2023
BUY CHAPTERS

Global Targeted Radiotherapy Drug Market Research Report 2024

Code: QYRE-Auto-2U15903
Report
August 2024
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Targeted Radiotherapy Drug Market Size

The global Targeted Radiotherapy Drug market was valued at US$ 5905 million in 2023 and is anticipated to reach US$ 8754.6 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.

Targeted Radiotherapy Drug Market

Targeted Radiotherapy Drug Market

Targeted radiotherapy is a medical treatment designed to direct radioactive isotopes to specific types of tumor cells or tumor markers, allowing for precise tumor treatment. These drugs offer a promising treatment for some malignant tumors, especially those that are advanced or difficult to surgically remove. As technology develops, treatment effects, as well as patient survival and quality of life after treatment, can be better monitored and evaluated. The development trend of targeted radiotherapy drugs emphasizes precise treatment, personalized treatment and comprehensive treatment methods. This will hopefully provide more effective cancer treatments in the future and improve patient survival and quality of life.
This report aims to provide a comprehensive presentation of the global market for Targeted Radiotherapy Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Radiotherapy Drug.

Report Scope

The Targeted Radiotherapy Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Targeted Radiotherapy Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Radiotherapy Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Targeted Radiotherapy Drug Market Report

Report Metric Details
Report Name Targeted Radiotherapy Drug Market
Accounted market size in 2023 US$ 5905 million
Forecasted market size in 2030 US$ 8754.6 million
CAGR 5.8%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Radioactive Iodine Therapeutic Drugs
  • Radioactive Antibody Therapeutic Drugs
  • Others
Segment by Application
  • General Hospital
  • Specialty Hospital
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Bayer, Endocyte, Progenics Pharmaceuticals, Jubilant Radiopharma, Curium, Fermi Energia, Nucleus RadioPharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Targeted Radiotherapy Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Targeted Radiotherapy Drug Market growing?

Ans: The Targeted Radiotherapy Drug Market witnessing a CAGR of 5.8% during the forecast period 2024-2030.

What is the Targeted Radiotherapy Drug Market size in 2030?

Ans: The Targeted Radiotherapy Drug Market size in 2030 will be US$ 8754.6 million.

Who are the main players in the Targeted Radiotherapy Drug Market report?

Ans: The main players in the Targeted Radiotherapy Drug Market are Novartis, Bayer, Endocyte, Progenics Pharmaceuticals, Jubilant Radiopharma, Curium, Fermi Energia, Nucleus RadioPharma

What are the Application segmentation covered in the Targeted Radiotherapy Drug Market report?

Ans: The Applications covered in the Targeted Radiotherapy Drug Market report are General Hospital, Specialty Hospital

What are the Type segmentation covered in the Targeted Radiotherapy Drug Market report?

Ans: The Types covered in the Targeted Radiotherapy Drug Market report are Radioactive Iodine Therapeutic Drugs, Radioactive Antibody Therapeutic Drugs, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Radiotherapy Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Radioactive Iodine Therapeutic Drugs
1.2.3 Radioactive Antibody Therapeutic Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Targeted Radiotherapy Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 General Hospital
1.3.3 Specialty Hospital
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Radiotherapy Drug Market Perspective (2019-2030)
2.2 Targeted Radiotherapy Drug Growth Trends by Region
2.2.1 Global Targeted Radiotherapy Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Targeted Radiotherapy Drug Historic Market Size by Region (2019-2024)
2.2.3 Targeted Radiotherapy Drug Forecasted Market Size by Region (2025-2030)
2.3 Targeted Radiotherapy Drug Market Dynamics
2.3.1 Targeted Radiotherapy Drug Industry Trends
2.3.2 Targeted Radiotherapy Drug Market Drivers
2.3.3 Targeted Radiotherapy Drug Market Challenges
2.3.4 Targeted Radiotherapy Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Radiotherapy Drug Players by Revenue
3.1.1 Global Top Targeted Radiotherapy Drug Players by Revenue (2019-2024)
3.1.2 Global Targeted Radiotherapy Drug Revenue Market Share by Players (2019-2024)
3.2 Global Targeted Radiotherapy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Targeted Radiotherapy Drug Revenue
3.4 Global Targeted Radiotherapy Drug Market Concentration Ratio
3.4.1 Global Targeted Radiotherapy Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Radiotherapy Drug Revenue in 2023
3.5 Targeted Radiotherapy Drug Key Players Head office and Area Served
3.6 Key Players Targeted Radiotherapy Drug Product Solution and Service
3.7 Date of Enter into Targeted Radiotherapy Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Radiotherapy Drug Breakdown Data by Type
4.1 Global Targeted Radiotherapy Drug Historic Market Size by Type (2019-2024)
4.2 Global Targeted Radiotherapy Drug Forecasted Market Size by Type (2025-2030)
5 Targeted Radiotherapy Drug Breakdown Data by Application
5.1 Global Targeted Radiotherapy Drug Historic Market Size by Application (2019-2024)
5.2 Global Targeted Radiotherapy Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Targeted Radiotherapy Drug Market Size (2019-2030)
6.2 North America Targeted Radiotherapy Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Targeted Radiotherapy Drug Market Size by Country (2019-2024)
6.4 North America Targeted Radiotherapy Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Radiotherapy Drug Market Size (2019-2030)
7.2 Europe Targeted Radiotherapy Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Targeted Radiotherapy Drug Market Size by Country (2019-2024)
7.4 Europe Targeted Radiotherapy Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Radiotherapy Drug Market Size (2019-2030)
8.2 Asia-Pacific Targeted Radiotherapy Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Targeted Radiotherapy Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Targeted Radiotherapy Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Radiotherapy Drug Market Size (2019-2030)
9.2 Latin America Targeted Radiotherapy Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Targeted Radiotherapy Drug Market Size by Country (2019-2024)
9.4 Latin America Targeted Radiotherapy Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Radiotherapy Drug Market Size (2019-2030)
10.2 Middle East & Africa Targeted Radiotherapy Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Targeted Radiotherapy Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Targeted Radiotherapy Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Targeted Radiotherapy Drug Introduction
11.1.4 Novartis Revenue in Targeted Radiotherapy Drug Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Targeted Radiotherapy Drug Introduction
11.2.4 Bayer Revenue in Targeted Radiotherapy Drug Business (2019-2024)
11.2.5 Bayer Recent Development
11.3 Endocyte
11.3.1 Endocyte Company Detail
11.3.2 Endocyte Business Overview
11.3.3 Endocyte Targeted Radiotherapy Drug Introduction
11.3.4 Endocyte Revenue in Targeted Radiotherapy Drug Business (2019-2024)
11.3.5 Endocyte Recent Development
11.4 Progenics Pharmaceuticals
11.4.1 Progenics Pharmaceuticals Company Detail
11.4.2 Progenics Pharmaceuticals Business Overview
11.4.3 Progenics Pharmaceuticals Targeted Radiotherapy Drug Introduction
11.4.4 Progenics Pharmaceuticals Revenue in Targeted Radiotherapy Drug Business (2019-2024)
11.4.5 Progenics Pharmaceuticals Recent Development
11.5 Jubilant Radiopharma
11.5.1 Jubilant Radiopharma Company Detail
11.5.2 Jubilant Radiopharma Business Overview
11.5.3 Jubilant Radiopharma Targeted Radiotherapy Drug Introduction
11.5.4 Jubilant Radiopharma Revenue in Targeted Radiotherapy Drug Business (2019-2024)
11.5.5 Jubilant Radiopharma Recent Development
11.6 Curium
11.6.1 Curium Company Detail
11.6.2 Curium Business Overview
11.6.3 Curium Targeted Radiotherapy Drug Introduction
11.6.4 Curium Revenue in Targeted Radiotherapy Drug Business (2019-2024)
11.6.5 Curium Recent Development
11.7 Fermi Energia
11.7.1 Fermi Energia Company Detail
11.7.2 Fermi Energia Business Overview
11.7.3 Fermi Energia Targeted Radiotherapy Drug Introduction
11.7.4 Fermi Energia Revenue in Targeted Radiotherapy Drug Business (2019-2024)
11.7.5 Fermi Energia Recent Development
11.8 Nucleus RadioPharma
11.8.1 Nucleus RadioPharma Company Detail
11.8.2 Nucleus RadioPharma Business Overview
11.8.3 Nucleus RadioPharma Targeted Radiotherapy Drug Introduction
11.8.4 Nucleus RadioPharma Revenue in Targeted Radiotherapy Drug Business (2019-2024)
11.8.5 Nucleus RadioPharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Targeted Radiotherapy Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Radioactive Iodine Therapeutic Drugs
    Table 3. Key Players of Radioactive Antibody Therapeutic Drugs
    Table 4. Key Players of Others
    Table 5. Global Targeted Radiotherapy Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Targeted Radiotherapy Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Targeted Radiotherapy Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Targeted Radiotherapy Drug Market Share by Region (2019-2024)
    Table 9. Global Targeted Radiotherapy Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Targeted Radiotherapy Drug Market Share by Region (2025-2030)
    Table 11. Targeted Radiotherapy Drug Market Trends
    Table 12. Targeted Radiotherapy Drug Market Drivers
    Table 13. Targeted Radiotherapy Drug Market Challenges
    Table 14. Targeted Radiotherapy Drug Market Restraints
    Table 15. Global Targeted Radiotherapy Drug Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Targeted Radiotherapy Drug Market Share by Players (2019-2024)
    Table 17. Global Top Targeted Radiotherapy Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radiotherapy Drug as of 2023)
    Table 18. Ranking of Global Top Targeted Radiotherapy Drug Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by Targeted Radiotherapy Drug Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Targeted Radiotherapy Drug Product Solution and Service
    Table 22. Date of Enter into Targeted Radiotherapy Drug Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Targeted Radiotherapy Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Targeted Radiotherapy Drug Revenue Market Share by Type (2019-2024)
    Table 26. Global Targeted Radiotherapy Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Targeted Radiotherapy Drug Revenue Market Share by Type (2025-2030)
    Table 28. Global Targeted Radiotherapy Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Targeted Radiotherapy Drug Revenue Market Share by Application (2019-2024)
    Table 30. Global Targeted Radiotherapy Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Targeted Radiotherapy Drug Revenue Market Share by Application (2025-2030)
    Table 32. North America Targeted Radiotherapy Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America Targeted Radiotherapy Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America Targeted Radiotherapy Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe Targeted Radiotherapy Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe Targeted Radiotherapy Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe Targeted Radiotherapy Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific Targeted Radiotherapy Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific Targeted Radiotherapy Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific Targeted Radiotherapy Drug Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America Targeted Radiotherapy Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America Targeted Radiotherapy Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America Targeted Radiotherapy Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa Targeted Radiotherapy Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa Targeted Radiotherapy Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa Targeted Radiotherapy Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Novartis Company Detail
    Table 48. Novartis Business Overview
    Table 49. Novartis Targeted Radiotherapy Drug Product
    Table 50. Novartis Revenue in Targeted Radiotherapy Drug Business (2019-2024) & (US$ Million)
    Table 51. Novartis Recent Development
    Table 52. Bayer Company Detail
    Table 53. Bayer Business Overview
    Table 54. Bayer Targeted Radiotherapy Drug Product
    Table 55. Bayer Revenue in Targeted Radiotherapy Drug Business (2019-2024) & (US$ Million)
    Table 56. Bayer Recent Development
    Table 57. Endocyte Company Detail
    Table 58. Endocyte Business Overview
    Table 59. Endocyte Targeted Radiotherapy Drug Product
    Table 60. Endocyte Revenue in Targeted Radiotherapy Drug Business (2019-2024) & (US$ Million)
    Table 61. Endocyte Recent Development
    Table 62. Progenics Pharmaceuticals Company Detail
    Table 63. Progenics Pharmaceuticals Business Overview
    Table 64. Progenics Pharmaceuticals Targeted Radiotherapy Drug Product
    Table 65. Progenics Pharmaceuticals Revenue in Targeted Radiotherapy Drug Business (2019-2024) & (US$ Million)
    Table 66. Progenics Pharmaceuticals Recent Development
    Table 67. Jubilant Radiopharma Company Detail
    Table 68. Jubilant Radiopharma Business Overview
    Table 69. Jubilant Radiopharma Targeted Radiotherapy Drug Product
    Table 70. Jubilant Radiopharma Revenue in Targeted Radiotherapy Drug Business (2019-2024) & (US$ Million)
    Table 71. Jubilant Radiopharma Recent Development
    Table 72. Curium Company Detail
    Table 73. Curium Business Overview
    Table 74. Curium Targeted Radiotherapy Drug Product
    Table 75. Curium Revenue in Targeted Radiotherapy Drug Business (2019-2024) & (US$ Million)
    Table 76. Curium Recent Development
    Table 77. Fermi Energia Company Detail
    Table 78. Fermi Energia Business Overview
    Table 79. Fermi Energia Targeted Radiotherapy Drug Product
    Table 80. Fermi Energia Revenue in Targeted Radiotherapy Drug Business (2019-2024) & (US$ Million)
    Table 81. Fermi Energia Recent Development
    Table 82. Nucleus RadioPharma Company Detail
    Table 83. Nucleus RadioPharma Business Overview
    Table 84. Nucleus RadioPharma Targeted Radiotherapy Drug Product
    Table 85. Nucleus RadioPharma Revenue in Targeted Radiotherapy Drug Business (2019-2024) & (US$ Million)
    Table 86. Nucleus RadioPharma Recent Development
    Table 87. Research Programs/Design for This Report
    Table 88. Key Data Information from Secondary Sources
    Table 89. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Targeted Radiotherapy Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Targeted Radiotherapy Drug Market Share by Type: 2023 VS 2030
    Figure 3. Radioactive Iodine Therapeutic Drugs Features
    Figure 4. Radioactive Antibody Therapeutic Drugs Features
    Figure 5. Others Features
    Figure 6. Global Targeted Radiotherapy Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Targeted Radiotherapy Drug Market Share by Application: 2023 VS 2030
    Figure 8. General Hospital Case Studies
    Figure 9. Specialty Hospital Case Studies
    Figure 10. Targeted Radiotherapy Drug Report Years Considered
    Figure 11. Global Targeted Radiotherapy Drug Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Targeted Radiotherapy Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Targeted Radiotherapy Drug Market Share by Region: 2023 VS 2030
    Figure 14. Global Targeted Radiotherapy Drug Market Share by Players in 2023
    Figure 15. Global Top Targeted Radiotherapy Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Radiotherapy Drug as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Targeted Radiotherapy Drug Revenue in 2023
    Figure 17. North America Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Targeted Radiotherapy Drug Market Share by Country (2019-2030)
    Figure 19. United States Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Canada Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Targeted Radiotherapy Drug Market Share by Country (2019-2030)
    Figure 23. Germany Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. France Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. U.K. Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Italy Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Russia Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Nordic Countries Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Targeted Radiotherapy Drug Market Share by Region (2019-2030)
    Figure 31. China Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Japan Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. South Korea Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Southeast Asia Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. India Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Australia Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Targeted Radiotherapy Drug Market Share by Country (2019-2030)
    Figure 39. Mexico Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Brazil Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Targeted Radiotherapy Drug Market Share by Country (2019-2030)
    Figure 43. Turkey Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Saudi Arabia Targeted Radiotherapy Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Novartis Revenue Growth Rate in Targeted Radiotherapy Drug Business (2019-2024)
    Figure 46. Bayer Revenue Growth Rate in Targeted Radiotherapy Drug Business (2019-2024)
    Figure 47. Endocyte Revenue Growth Rate in Targeted Radiotherapy Drug Business (2019-2024)
    Figure 48. Progenics Pharmaceuticals Revenue Growth Rate in Targeted Radiotherapy Drug Business (2019-2024)
    Figure 49. Jubilant Radiopharma Revenue Growth Rate in Targeted Radiotherapy Drug Business (2019-2024)
    Figure 50. Curium Revenue Growth Rate in Targeted Radiotherapy Drug Business (2019-2024)
    Figure 51. Fermi Energia Revenue Growth Rate in Targeted Radiotherapy Drug Business (2019-2024)
    Figure 52. Nucleus RadioPharma Revenue Growth Rate in Targeted Radiotherapy Drug Business (2019-2024)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Immunotherapy Drugs for Neuroblastoma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-39R14639
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Cancer Early Detection and Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37I14671
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global One-Stop Radiotherapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-33G18542
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Immunotherapy for Neuroblastoma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-1A14903
Thu Dec 12 00:00:00 UTC 2024

Add to Cart